Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 3:32 pm Purchase | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,956,064 11.8% | 504,058 (+9.25%) | View |
| 2023-02-10 2:10 pm Sale | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,873,436 7.65% | -3,085 (-0.08%) | View |
| 2023-02-09 11:22 am Purchase | 13G | Haemonetics Corporation HAE | VANGUARD GROUP INC | 5,242,836 10.36% | 47,641 (+0.92%) | View |
| 2023-02-06 3:00 pm Sale | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 4,034,753 7.97% | -1,502,785 (-27.14%) | View |
| 2023-01-26 08:52 am Unchanged | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 5,898,620 11.7% | 0 (Unchanged) | View |
| 2023-01-20 3:00 pm Sale | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 5,898,620 11.7% | -793,726 (-11.86%) | View |
| 2022-10-11 10:07 am Purchase | 13G | Haemonetics Corporation HAE | VANGUARD GROUP INC | 5,195,195 10.12% | 314,259 (+6.44%) | View |
| 2022-04-08 11:19 am Purchase | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,452,006 10.7% | 3,402,873 (+166.06%) | View |
| 2022-02-14 2:29 pm Purchase | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,876,521 7.59% | 1,043,472 (+36.83%) | View |
| 2022-02-11 12:22 pm Sale | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,049,133 4% | -726,503 (-26.17%) | View |
| 2022-02-10 08:16 am Purchase | 13G | Haemonetics Corporation HAE | VANGUARD GROUP INC | 4,880,936 9.55% | 28,654 (+0.59%) | View |
| 2022-02-10 07:48 am Purchase | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 5,537,538 10.83% | 447,237 (+8.79%) | View |
| 2022-02-04 09:27 am Purchase | 13G | Haemonetics Corporation HAE | WELLINGTON MANAGEMENT GROUP LLP | 5,090,301 9.96% | 2,837,909 (+126.00%) | View |
| 2022-01-26 8:18 pm Unchanged | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 6,692,346 13.1% | 0 (Unchanged) | View |
| 2022-01-25 11:15 am Purchase | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 6,692,346 13.1% | 713,043 (+11.93%) | View |
| 2021-07-09 6:05 pm Purchase | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 5,979,303 11.7% | 1,278,712 (+27.20%) | View |
| 2021-06-10 11:46 am Sale | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,775,636 5.4% | -2,862,099 (-50.77%) | View |
| 2021-02-16 3:11 pm Purchase | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,637,735 11.1% | 437,670 (+8.42%) | View |
| 2021-02-11 7:05 pm Purchase | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 2,833,049 5.57% | 221,133 (+8.47%) | View |
| 2021-02-10 10:57 am Sale | 13G | Haemonetics Corporation HAE | VANGUARD GROUP INC | 4,852,282 9.56% | -378,913 (-7.24%) | View |